Trials / Completed
CompletedNCT00305630
Neovascular Age Related Macular Degeneration (AMD), Periocular Corticosteroids, and Photodynamic Therapy (PDT)
Neovascular Age Related Macular Degeneration, Periocular Corticosteroids, and Photodynamic Therapy
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 100 (planned)
- Sponsor
- Johns Hopkins University · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
Randomized controlled clinical trial of periocular corticosteroids as adjunctive therapy to photodynamic therapy (PDT) for patients with neovascular age-related macular degeneration (AMD). Patients undergoing PDT are randomized to either a periocular corticosteroid injection with 40 mg of triamcinolone acetonide or observation just prior to PDT. Patients are followed for 6 months. Primary outcome is leakage from choroidal neovascularization (CNV) at 3 months on fluorescein angiography.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Periocular injection of triamcinolone acetonide 40mg |
Timeline
- Start date
- 2002-07-01
- Completion
- 2005-11-01
- First posted
- 2006-03-22
- Last updated
- 2006-03-22
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00305630. Inclusion in this directory is not an endorsement.